GMP Requirements for Pharmaceutical Equipment: A Complete Buyer's Guide

GMP requirements for pharmaceutical equipment cover hygienic equipment design, suitable product-contact materials, cleanability, maintenance and calibration, equipment qualification such as DQ, IQ, OQ and PQ where applicable, validation documentation, and the controls needed to support consistent pharmaceutical production. Depending on the equipment and destination market, buyers may also need FAT/SAT records, electrical and machinery-safety documentation, data-integrity functions, CE conformity, ATEX documentation, or other project-specific compliance evidence.

FDA CGMP, EU GMP and WHO GMP provide important regulatory frameworks, but no single “GMP certificate” proves that a pharmaceutical machine is suitable for every application. This guide explains what buyers should check in GMP equipment, what documentation suppliers should provide, and what should be agreed before purchase, FAT, installation and qualification. FDA confirms that it does not maintain a list of approved pharmaceutical manufacturing equipment, while WHO and EU GMP guidance place equipment suitability and qualification within the wider pharmaceutical quality system.

What Are GMP Requirements for Pharmaceutical Equipment?

GMP requirements for pharmaceutical equipment are the design, control, maintenance, qualification and documentation expectations used to help ensure that pharmaceutical machine or pharmaceutical packaging machine is suitable for its intended pharmaceutical process and does not create unacceptable risks to product quality.

In practice, GMP equipment is not judged by one feature such as stainless steel construction. Buyers need to look at the complete equipment lifecycle—from the user requirement specification (URS) and equipment design to cleaning, calibration, qualification, operation, maintenance and supporting records.

The main areas include:

For buyers, the important point is that GMP compliance is demonstrated through evidence, not through a general sales claim. A supplier can design equipment around pharmaceutical requirements and provide technical records, FAT/SAT documents, calibration information and qualification support, but the pharmaceutical manufacturer remains responsible for determining whether the machine is suitable for its intended use within its own quality system.

This is also why different machines need different levels of attention. A tablet press or capsule filling machine has direct product-contact and powder-control concerns, while a blister packaging machine or cartoning machine introduces different risks involving packaging materials, labeling, inspection and traceability. The GMP approach should therefore follow the actual process rather than apply the same checklist blindly to every machine.

The practical evaluation sequence is:

design and materials → cleaning and maintenance → qualification and validation → supplier documentation → market-specific compliance → final buyer verification

The next section begins with the machine itself: the core GMP equipment requirements for design, materials, cleaning and maintenance.

Core GMP Equipment Design, Material, Cleaning and Maintenance Requirements

Good GMP equipment starts with a design that suits the product and process. FDA CGMP requirements focus on appropriate equipment design, cleaning and maintenance, while product-contact surfaces must not react with, add to or absorb materials in a way that adversely affects product quality. FDA also makes clear that there is no universal agency preference for one construction material for all production equipment.

GMP pharmaceutical equipment design showing cleanable product-contact parts

Product-Contact Materials and Hygienic Design

Stainless steel is widely used in pharmaceutical machinery, particularly around product-contact areas, but writing “316L stainless steel” on a specification does not by itself establish GMP suitability.

Buyers should consider material compatibility, corrosion resistance, surface condition, welds, seals, lubricants and any other components that can contact the product. Surface-finish requirements or specific material certificates should be defined when they matter to the actual process rather than treated as universal requirements for every pharmaceutical machine.

The physical design should also reduce areas where powder, granules, tablets, liquids or cleaning residues can accumulate. Product-contact parts that need routine cleaning should be accessible and, where appropriate, easy to remove and reinstall.

Cleaning, Maintenance and Calibration

Cleaning requirements should match the equipment and contamination risk. A tablet compression machine handling powders, for example, has different cleaning concerns from a secondary cartoning machine. CIP, automated cleaning or a specific disassembly design can be valuable, but none should be assumed to be mandatory for every machine.

FDA requires equipment to be cleaned and maintained at appropriate intervals, with written procedures and records supporting those activities. WHO also treats equipment cleaning and maintenance as part of maintaining equipment in a suitable qualified state.

Critical measuring instruments should also have an appropriate calibration strategy. During procurement, buyers should therefore check not only how the machine performs at FAT, but how it will be cleaned, inspected, calibrated and maintained over years of production.

Pharmaceutical Equipment Qualification and Validation Requirements

Pharmaceutical equipment qualification provides documented evidence that equipment has been designed, installed and operated for its intended purpose. In practice, equipment qualification in pharma normally follows a lifecycle rather than beginning when the machine arrives at the factory.

EU GMP Annex 15 starts that lifecycle with the user requirements specification (URS). The URS defines what the equipment must achieve, while design qualification (DQ) verifies that the proposed design addresses those requirements.

Pharmaceutical equipment qualification lifecycle from URS and DQ to FAT SAT IQ OQ and PQ

FAT and SAT Before IQ/OQ

A factory acceptance test (FAT) is an opportunity to verify agreed machine functions, specifications, alarms, controls and documentation at the supplier's site before shipment. A site acceptance test (SAT) can then confirm applicable functions after delivery.

FAT and SAT are not simply other names for IQ and OQ. However, EU GMP Annex 15 allows appropriate documentation reviews and some FAT testing to support later qualification without unnecessary repetition when this is justified and transport or installation has not affected the tested functionality.

IQ, OQ and PQ

Installation qualification (IQ) confirms that the installed system matches approved drawings, specifications and predefined requirements. Annex 15 identifies areas such as supplier instructions, maintenance requirements, instrumentation calibration and materials of construction as relevant IQ considerations.

Operational qualification (OQ) demonstrates that the installed equipment operates as intended across defined operating ranges, including appropriate challenge or limit testing.

Performance qualification (PQ) goes further by demonstrating effective and reproducible performance under conditions representative of the intended process. Because PQ depends strongly on the product, process and manufacturing site, the equipment supplier can support it, but should not present a generic PQ certificate as proof that every customer's process has already been validated.

This section intentionally summarizes equipment validation rather than turning the article into another complete IQ/OQ/PQ tutorial. Buyers should define the supplier's qualification responsibilities before ordering and use a dedicated IQ OQ PQ validation procedure for the detailed execution strategy.

GMP Documentation for Pharmaceutical Equipment: What Should Suppliers Provide?

Strong GMP documentation is where equipment design, testing and qualification become traceable evidence. Buyers should define required supplier documents early—ideally during URS, RFQ or purchase-order review—rather than asking for missing documents after FAT.

A practical pharmaceutical equipment documentation package can include:

Pharmaceutical equipment documentation package including FAT calibration and IQ OQ records

The exact package should reflect the machine and project. A simple secondary packaging machine will not necessarily require the same validation documentation as a complex production system with multiple critical instruments and computerized controls.

In larger projects, buyers may define these deliverables through vendor document requirements (VDR). Final approved documents can then be compiled into a vendor documentation package or turnover package (TOP) for equipment handover.

One distinction is especially important: supplier documents support qualification, but they do not automatically replace the pharmaceutical manufacturer's own controlled procedures or approval process. EU GMP Annex 15 states that third-party validation protocols and documentation should be reviewed by appropriate site personnel for suitability and compliance with internal procedures, and vendor protocols can require additional documentation or testing.

This is why the document list should be agreed before purchase. If the project needs material certificates, calibration records, FAT reports or specific IQ/OQ documentation, these requirements should appear in the commercial and technical scope rather than remain an assumption.

Rich Packing can provide pharmaceutical equipment documentation and qualification support according to the agreed project scope.

Pharmaceutical Equipment Compliance and Certification Requirements by Market

Pharmaceutical equipment compliance is not identical across every destination market. GMP addresses pharmaceutical manufacturing quality, while machinery safety, electrical conformity, explosion protection and electronic-record requirements come from separate regulatory or technical frameworks.

In the United States, FDA does not “approve” individual production machines. The user remains responsible for selecting equipment capable of meeting applicable CGMP requirements. If a computerized system creates, modifies, maintains or transmits electronic records required under FDA regulations, 21 CFR Part 11 can become relevant; it should not be applied automatically to every HMI or PLC simply because it is installed on pharmaceutical equipment.

For equipment placed on the EU market, CE conformity is also separate from GMP qualification. As of September 2026, the European Commission states that machinery placed on the EU market before 20 January 2027 remains under Machinery Directive 2006/42/EC, while Regulation (EU) 2023/1230 becomes mandatory from that date. Buyers with 2026–2027 projects should therefore confirm which legislation applies at the actual placing-on-market date.

ATEX documentation becomes relevant where equipment is intended for applicable potentially explosive atmospheres. Other electrical, pressure, safety or local-code requirements likewise depend on the machine, installation and destination.

A buyer should therefore ask:

Which requirements actually apply to this machine, this product, this facility and this market?

That question is more useful than requesting every certificate seen on another pharmaceutical project.

GMP Equipment Checklist Before Purchase, FAT and Shipment

GMP equipment checklist covering purchase FAT shipment and installation stages

A practical GMP equipment checklist should follow the purchasing lifecycle rather than wait until final delivery.

The biggest procurement problems often come from requirements that were never written down. If a buyer expects a particular certificate, FAT challenge test, material record, software function or IQ/OQ protocol, it should be defined before the order is finalized.

The same principle applies to complete pharmaceutical production lines. A tablet press, capsule filling machine, counting line, blister packaging machine and cartoning machine may be connected into one project, but each machine can have different product-contact, cleaning, control and qualification requirements. The line should therefore be evaluated both as individual equipment and as an integrated system where interfaces can affect performance.

For new pharmaceutical production or packaging projects, contact Rich Packing to discuss equipment configuration, FAT scope and documentation requirements.

Conclusion

The GMP requirements for pharmaceutical equipment cannot be reduced to stainless steel construction or one “GMP certificate.” Good GMP equipment combines suitable design, cleanability, maintainability, appropriate controls, equipment qualification and reliable documentation.

For buyers, the most effective approach is to define these requirements in the URS and purchasing documents before manufacturing begins. That makes FAT, IQ/OQ, document handover and final site qualification much easier—and reduces the risk of discovering missing compliance evidence after the equipment has already been shipped.

Frequently Asked Questions

References

1. FDA — Questions and Answers on Current Good Manufacturing Practice Requirements: Equipment. FDA Equipment CGMP Q&A
2. European Commission — EU GMP Annex 15: Qualification and Validation. EU GMP Annex 15
3. WHO — Quality Assurance of Pharmaceuticals: GMP and Inspection, 10th Edition. WHO GMP Compendium
4. FDA — Part 11, Electronic Records; Electronic Signatures — Scope and Application. FDA Part 11 Guidance
5. European Commission — Machinery: Directive 2006/42/EC and Regulation (EU) 2023/1230. European Commission Machinery Rules